CXCL12 and cancer: For example, the presence of a stromal-derived growth factor (SDF-1—CXCL12) and its receptor CXCR4 on bone marrow endothelial cells has been shown to be favourable to cancer cell extravasation from the circulation and their retention in bone marrow [10].